Survivin is a member of the inhibitors of the apoptosis protein (IAP) family, and undetectable in normal adult tissues but highly expressed in several types of cancer, with a potential involvement in malignant transformation and tumor growth [4, 5]. Here, BIRC5 is linked to neoplasm.